Brief: Glaxosmithkline Pharmaceuticals Approved Commercial Transformation Initiative
16/11/2023 14:17
Nov 16 (Reuters) - GlaxoSmithKline Pharmaceuticals Ltd
GLAX.NS :
* GLAXOSMITHKLINE PHARMACEUTICALS LTD - APPROVED COMMERCIAL
TRANSFORMATION INITIATIVE
* GLAXOSMITHKLINE PHARMACEUTICALS LTD - WILL EXPLORE NEW
INNOVATIVE SOLUTIONS INCLUDING OMNICHANNEL STRATEGY TO EXPAND
ITS REACH AND COVERAGE TO TARGET SEGMENTS
* GLAXOSMITHKLINE PHARMACEUTICALS - LAUNCHED VOLUNTARY
RETIREMENT
SCHEME FOR COMMERCIAL FUNCTION EMPLOYEES
Source text for Eikon: ID:nBSE1x4wMG
Further company coverage: GLAX.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on GlaxoSmithKline Pharmaceuticals
See all newsGSK India first-quarter profit rises on steady vaccine demand
Brief: Glaxosmithkline Pharma Q1 Consol Profit 2.37 Billion Rupees
Brief: Glaxosmithkline Pharmaceuticals: Receives Demand Notice From National Pharmaceutical Pricing Authority
India's GlaxoSmithKline Pharma gains after Q4 profit rise; PT hike
Brief: Glaxosmithkline Pharmaceuticals March-Quarter Consol Profit 2.78 Billion Rupees